<SEC-DOCUMENT>0001013762-24-000532.txt : 20240827
<SEC-HEADER>0001013762-24-000532.hdr.sgml : 20240827
<ACCEPTANCE-DATETIME>20240722171745
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001013762-24-000532
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20240722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		7209402200

	MAIL ADDRESS:	
		STREET 1:		10170 CHURCH RANCH WAY
		STREET 2:		SUITE 100
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; width: 60%; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"><IMG SRC="image_001.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; width: 40%; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilson
Sonsini Goodrich &amp; Rosati<BR>
Professional Corporation</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1881
    9<SUP>th</SUP> Street</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boulder,
Colorado 80302-5148</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">o</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">:
    303.256.5900<BR>
    <FONT STYLE="font-variant: small-caps">f</FONT>: 866.974.7329</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 22, 2024&nbsp;</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Via
EDGAR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Life Sciences</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
F Street, N.E.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549-3628</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ibolya Ignat, Daniel Gordon, Tamika Sheppard and Joshua Gorsky</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARCA
biopharma, Inc.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment
No. 2 Registration Statement on Form S-4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
July 9, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
No. 333-279387</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of ARCA biopharma, Inc. (the &ldquo;<U>Company</U>&rdquo;), we are submitting this letter to the Securities and Exchange Commission
(the &ldquo;<U>SEC</U>&rdquo;) via EDGAR in response to the comment letter from the staff of the SEC (the &ldquo;<U>Staff</U>&rdquo;),
dated July 16, 2024 (the &ldquo;<U>Comment Letter</U>&rdquo;), pertaining to the Company&rsquo;s above-referenced Registration Statement
on Form S-4/A (the &ldquo;<U>First Amended Registration Statement</U>&rdquo;). In connection with such responses, the Company is concurrently
filing Amendment No. 3 to the Second Amended Registration Statement (the &ldquo;<U>Third Amended Registration Statement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
your convenience, the Staff&rsquo;s comments are summarized in this letter, and each comment is followed by the applicable responses
on behalf of the Company. Unless otherwise indicated, page references in the responses correspond to the page numbers in the Second Amended
Registration Statement. Capitalized terms used in this letter but otherwise not defined herein shall have the meanings set forth in the
Second Amended Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Amendment
No. 2 to Registration Statement on Form S-4</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Opinion
of Lucid, ARCA&rsquo;s Financial Advisor, to ARCA&rsquo;s Board of Director, page 112</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
                                            note your disclosure that Lucid, in connection with its opinion, &quot;[r]eviewed and analyzed
                                            certain internal financial analyses, including . . . projections as to cost and expenses
                                            . . . and other information concerning Oruka prepared by Oruka[.]&quot; Please disclose these
                                            financial projections and discuss the material assumptions and limitations underlying the
                                            financial projections or, alternatively, please explain why such disclosures are not required
                                            pursuant to Item 4(b) of Form S-4 and Item 1015(b)(6) of Regulation MA.</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Response</U>:
The Company respectfully acknowledges the Staff&rsquo;s comment and advises the Staff that the requested disclosure was previously included
on pages 113 and 264 of the Third Amended Registration Statement. The Company respectfully directs the staff to the language set forth
on pages 113 and 264, which is as follows: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Further,
as ARCA&rsquo;s board of directors was aware, Oruka&rsquo;s management did not provide Lucid with, and Lucid did not otherwise have access
to, financial forecasts regarding Oruka&rsquo;s businesses, other than certain cash burn projections, and, accordingly, Lucid did not
perform either a discounted cash flow analysis or any multiples-based&nbsp;analyses with respect to Oruka.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">austin
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;beijing
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;boston
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BOULDER
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;brussels
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hong kong
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;london
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; los angeles
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;new york
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;palo alto
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SALT LAKE CITY
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;san diego
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;san francisco
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; seattle
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shanghai
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;washington, dc
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;wilmington, de</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
22, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the Staff&rsquo;s comment, the Company has revised the above disclosure on page 113 of the Third Amended Registration Statement
to clarify that the expected net proceeds from the Merger and the Oruka pre-closing financing, together with Oruka&rsquo;s existing cash
and sales of additional convertible notes under the Purchase Agreement, will enable Oruka to fund its operating expenses through 2027.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*****</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
contact the undersigned at (303) 256-5901 or via email at bfassett@wsgr.com if you have any questions with respect to the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brent D. Fassett</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brent D. Fassett</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left">
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilson Sonsini Goodrich &amp; Rosati P.C.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
                                            A Keuer, <I>ARCA biopharma, Inc.</I></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Jeffrey Dekker, <I>ARCA biopharma, Inc. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ethan
Lutske, <I>Wilson Sonsini Goodrich &amp; Rosati P.C. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ross
Tanaka, <I>Wilson Sonsini Goodrich &amp; Rosati P.C.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Savir
S. Punia, <I>Wilson Sonsini Goodrich &amp; Rosati P.C.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ryan
A. Murr, <I>Gibson, Dunn &amp; Crutcher LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Branden
C. Berns, <I>Gibson, Dunn &amp; Crutcher LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  P ( # 2(  A$! Q$!_\0
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M3+\13E*K"$^(<?*I2Q\ZE/FC"I4HT,!=2G";C*O+E<7=G\O/[?GQ;^*N@_\
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M-QX:U6<R)HH\,>%=8E\,2PVDVMSJU[>V]OIWY[_M2_\ !!S]EK]L;XE_$/\
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MX3:W?YCSI^OM&]UX8N[IC'HGBO[/(\D&EZEK(E_(O]H?]MKXP_M"?"C]DO\
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FHUL1GF8XB6&E3J^UIRK\1X2O*FX2I1JOV;J3@VZ2;]FVTO>M_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  8 $ # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z/_:/G^/M
MEKG[0/\ P0R^$7B+Q5I7Q'^*7[<MW\8O@OX@GU'7$AT?]DSQ-\/]6_:!;0X-
M=LIOM3:=X9\:>';?34MVO[:26;[782EE$A;[S_X):_'CQG_P4A_;"^%_QZ\0
MW/B:T\+?L,_L1^!/A%XQT>^.HV&GZG^U_P#$BYU/1_B?J]U92R?8]1DL=!\)
MZGY3%)9+1;S1+HNLDJL?O/2/VJ?^"5'Q _X**Z'JFC>)M+U_]MC1M-U_]F#P
MY\0;'PE\39?"MU?6%Y?:MKWPNTSQY!HO_"JM5\8Z7)<ZQ'*$U*XUFTLI-4TZ
M&^%GYT%>C^(OB?\ \$W?^"44WB?1;O5O#_P8\1?M&?$#Q/\ &?6O WA?3?''
MQ#\=>-O$VKR*GB'Q=:^"?#-GXM\2:=X:M6MVB22TTS3O"NF>3=P6*0NET@^P
MQ&.G4PRP<<JQ4,?B,(JE*;P_OU,1BH4J&:8B,5#GE1JX3"X;V+LO9U:F)E+V
M?M$Y?E6 R>E0S!YK/B7+:N1X#-)4,116.O1H8++:V)QG#N!G-U/8PQ>'S/,L
MP^MQYI>WPU# 4J7M_8.-/X)^ 6OZ]/X!_P"#BB2;7-8FDT'XV?M/0Z%)+JE]
M))HD5M\ -0FMHM(=YRVF1V\P66!+(P+#(JO&%95(_2K_ ()87VHZQ_P31_8I
MO+S5KF?6-0_9C^&$\^KWTS:C>M>W'A2T)O[J6[DD>[F65O.D-Q(QE92)&Y-8
M/PNF_P""=U_^S;^U7^TQ\*O$OACQ+^SO^TF/B3\3?VF?'&@^(_%6O:?KD\_A
M2XT+XD2:GIOVJXUWPEJEMX<6>WU'PSI>G:-J=BTJSQ:9#<W$,C_/W[/'PX_X
M))_L<?#+P!^V'\"]6?P]\*?C1%X?^"W@?QC_ ,+!^-'Q"\+:RWQ'UN+3-+\(
MQ^#?$&N>([30KV?6]);3;];O0--N=!N+2]LM0?3P+F,\&*J1Q5'$TEA\;3J_
M7<'[**P?,G7P^4T<)4PM5\T)4JCE0K5XQY9RE3CS.G=R:]K+J-3+L5E^(>.R
MBOAEE.:O$S>:^S<<%CN)\7F=#,<,O9U88K#PIXS#82=3VE*$*\_9QKV5.,_S
M6_8_^'OA_P#8C_:V^"NH?ML_ _QUXH^.7QP^/?Q#\+?"'_@I5\*OV@];^(/P
MT_:1UOXD7>N)X3\'?%KP38>)[6;1H]/TF-M/TOP_K&BZII.FW^D6>K06*Q6=
MYJ<'U]\0_A#X._X*&?\ !5/]J/\ 9D_;$U_Q=J/P0_9K^#?P3U_X"_LVV/CG
MQ%X%\(?$I_B/HSZOX[^->O6/AC4M%O\ QU?>%_$('@^PD>\N;#P[B*"6"&[$
MAFM?$KP'_P $1?\ @E]^T9X-\8>+?#<O@GXT6UEKGQ/\$^"-!'QR^+^@_"31
M]2N9;#6_BAI7PMT2X\7^#_A5I<UREY;KXF_L+2$BD6]?371HY)$^O/VP_AI_
MP3:_:=OOV5-7_:1LK35O%7QUU.V\*_LN?$3PIJGQ)\!>/?$0\1Z(/%4.A:/X
M\^'5SX>\2Z9X?UC1[G^T&T_Q#J-GI#F\D'DQW5W,LG96Q;GB*6,C1S*'UK 5
MJ%+'1PS4J=6$XUO;8##SK5(TZ=/#4:M.M'#XBG"$)UJN#5"E&4#R<)E:HX'%
M954Q7#]99=G6$QF)R:IF"E#$8>K1J8187/,=3PN'J5ZV(Q^+PV(PM3'8*O5J
M5J6%PV:O&XB<*I\3?L9ZEX@^%UO_ ,%C/V1/!/Q#\9?$S]FC]ECP]%#\ /%7
MBGQ5J?C'5/A[J7CKX+>--=\??!73_&]_<7-_JME\-=9TW3%L;9[ZXO/#KWTE
MM>2+>7#$_@#XE_:F_:5_9Z_X)*P_LL_M#^(/%^O^#_VI/AC\+OCE^P_\==(U
M'7)Y;!H?B3X:UCXJ? 'Q3X@^T?VEIVI>%XTN]7T+S+MH(["_^RI*-,UC2+#3
M?[&/V>(O^"?O@/4?BQ_P3:_9^A\$>%==^'GA6:\^*OP3TF+7;#7KK0_B+H]M
M%JGB+4]>U4#4O&>HZKIFLZ='KGB&'7=9U:P&HZ7%?W=IOL47YI^).E_\$BOB
M'_P3GCTOXC6FA:Y^PI^S+XRC\ V-]>P_$S[7\//&?P^\3)X.-GI6KVR)\16O
M8-8UAM#N=0L[BYAUBPU2>*XN+O3YW8:X7,J5/$S=;+<57IU\=E6(N\-!8B3I
MX1T\/BX<L5".)QN)@Z_LH)T<52JUZ?/.:]H<^8\/XBOE]..%X@RW!U\)DW$N
M 45CZL\!35?-%7Q^65>>I*K/+\HRZM'"+$U7'%9=B,-@ZZITJ+]BORZ^$'[1
M\7[-'[6/@CX'_P#!/GXH?$+XM>%OB=^U_K,7Q?\ ^"=/QZ_9O\4>'_B/^S[I
MGC/7K]_B9\;_  9\6+G1=.O?"W@O18+F;6M/B\3WM[9R:3J5JET;NY?5FB^W
MO$_QG\!?\$\?^"FW[8/Q^_;3TSQ1HOPL_:<\!? VT_9S_:2B\">)O&_@WP?I
M'P[\-ZAHWCGX#:GJ_AG1];N_ VL:GXGEA\76.GSPVEGXK$L,SR2W<%BCE%=%
M>E2J9IEN G!N.;Y7AUB\1S*.*E];=/%1DZL*<(U)T)82%)3J4N?$4I2CBG4D
MH37#@\5B:'#>?YU2J0C4X7XBQL\LP#IRJ9;3_LV%;+ZD(X>M7K5:-+&0S2MB
M'1H8E4L#B:<)Y="A3G5I2^</A]X;\6>*?V6/^"[/[5G@[X9^,?A+^SA^U1X7
M\7>)OV=?A]XI\)WGA#6_%K>%_@OJV@>-/C-9^!;J"#4]$L/BKX@DAU?3Q=:=
M:WNMA9)I8'6V@EE_,/XH_LX_M#_L=_LX?L)^#_ .G>)?'G[%/[8_C_\ 8*^/
ME]9ZL^K:IJG[.'[35O8^#-9^(&C6Z>7++9^&?BI'J%]JUDE\L-NM[I,]@!:W
MVD^9KA148/,*D<0X*G3=*KF[PLJ4W*:Y,'E-3#X6KSR]]XBD\-&LJUU*4YU8
MR3I3Y%KFF14*F"A6>(KPQ.&X7AF5/$4E3I?O<VXHH8W,L.J,/W,<#BEF%3#/
M"*+A3HT<-.G*.(HJK+]>?^"JGQ4^$'[-'[7-]\=_ ?[1OQ4_9/\ VP+K]G6V
M\(V#>)_V<]:^-/[-'[6OA*VUC4-9\/\ P1^71;]4\?\ ]MPI83WOAO4;"_TV
M'5-*,D<[PW31]G^T1XV^+'QCUC_@@)\4/BW\,[CX9?$SQ7^T=I/B?XA> ;72
M]3LX/!>KZA\*[N2YLY=-OUDU'0;8KLN8])U>0WVCQS?V;?2O<V<[DHK**A#!
M9%6Y>>K7PV:Q=2;3J4Z>&P./P\:$)QA"4J+=5U8PJNJZ,E[.C4C2E*!T5)5:
M^;\:X3VGLL+@LPX:DL/1C*-&OB,?G62X^IC*M*I6K4X8N*P\<-.KA5AH8JG+
MVV*H3Q,(53Y"^+O[*_QR^(W_  5%_P""E?[4G[+E_KVB_M6?L@:C^R+\1_@K
MI+2W5IX1^-'A?7/A1XFMOBW\$]>A;R[74X/'FB:%8Z?8R1R!XM4B@TV2YTY-
M2;4+3PC3;CQ5XQ_X-LOVNM;U?P=K'ASQ/XN_:?\ B-XFOO!LFGZF=2T:\UK]
MH'P;JEYI7V2[M8=2<:7--/:R//:QRJ+:1ITC=)%4HK>CC*E1X.A.$)+#8GA5
MTJEFJBINE*3H.2^*DJO-6@I)RISJ5%%\DW%<N,RBA1CFF+I5:T'F&6^)2Q-&
B\70EB%B8THXR,'?DQ#PSIX6JX.,*]*AAY58.K251_P#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
